Cramer Rosenthal McGlynn’s Claritev Corp CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-56,627
Closed -$12.8M 98
2021
Q3
$12.8M Sell
56,627
-35,603
-39% -$9.63M 0.44% 76
2021
Q2
$35.1M Sell
92,230
-5,458
-6% -$1.69M 1.13% 32
2021
Q1
$21.7M Sell
97,688
-10,211
-9% -$2.94M 0.72% 54
2020
Q4
$34.5M Buy
107,899
+46,272
+75% +$15.4M 1.08% 37
2020
Q3
$25.3M Buy
+61,627
New +$27.1M 1.02% 40

Other funds holding CTEV

Cramer Rosenthal McGlynn's CTEV Position: Q4 2021 in Review

Cramer Rosenthal McGlynn sold out of Claritev Corp (CTEV) in Q4 2021, closing a stake of 56,627 shares — an estimated $12.8M sold.

Cramer Rosenthal McGlynn first reported a position in CTEV in Q3 2020 and held it in 5 quarters. The position peaked at $35.1M in Q2 2021. 135 funds tracked by Wall St. Rank hold CTEV as of Q4 2021.

  • Cramer Rosenthal McGlynn reported no remaining Claritev Corp position as of Q4 2021 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 56,627 Claritev Corp shares in Q4 2021, an estimated $12.8M.
  • Cramer Rosenthal McGlynn first reported a position in Claritev Corp in Q3 2020 and held it in 5 quarters.
  • Cramer Rosenthal McGlynn's Claritev Corp position peaked at $35.1M in Q2 2021.
  • 135 funds tracked by Wall St. Rank held Claritev Corp as of Q4 2021.

Based on Cramer Rosenthal McGlynn's 13F filing for Q4 2021, filed 14 Feb 2022.